X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE STERLING BIOTECH TTK HEALTHCARE/
STERLING BIOTECH
 
P/E (TTM) x 29.1 -1.8 - View Chart
P/BV x 5.4 0.1 7,816.8% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 TTK HEALTHCARE   STERLING BIOTECH
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
STERLING BIOTECH
Dec-13
TTK HEALTHCARE/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs66311 6,318.1%   
Low Rs3993 11,735.3%   
Sales per share (Unadj.) Rs535.626.8 1,998.1%  
Earnings per share (Unadj.) Rs15.9-15.0 -106.6%  
Cash flow per share (Unadj.) Rs20.0-5.5 -366.6%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.654.9 250.8%  
Shares outstanding (eoy) m7.77267.87 2.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.3 382.5%   
Avg P/E ratio x33.3-0.5 -7,169.1%  
P/CF ratio (eoy) x26.5-1.3 -2,084.9%  
Price / Book Value ratio x3.90.1 3,048.1%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,1271,862 221.7%   
No. of employees `0001.71.4 126.1%   
Total wages/salary Rs m607547 110.9%   
Avg. sales/employee Rs Th2,436.75,303.3 45.9%   
Avg. wages/employee Rs Th355.2403.8 87.9%   
Avg. net profit/employee Rs Th72.5-2,959.0 -2.5%   
INCOME DATA
Net Sales Rs m4,1627,181 58.0%  
Other income Rs m6143 143.7%   
Total revenues Rs m4,2237,223 58.5%   
Gross profit Rs m197947 20.8%  
Depreciation Rs m322,543 1.2%   
Interest Rs m304,377 0.7%   
Profit before tax Rs m197-5,931 -3.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-1,924 -3.8%   
Profit after tax Rs m124-4,007 -3.1%  
Gross profit margin %4.713.2 35.9%  
Effective tax rate %37.032.4 114.1%   
Net profit margin %3.0-55.8 -5.3%  
BALANCE SHEET DATA
Current assets Rs m1,62914,335 11.4%   
Current liabilities Rs m1,05849,809 2.1%   
Net working cap to sales %13.7-494.0 -2.8%  
Current ratio x1.50.3 535.0%  
Inventory Days Days30403 7.4%  
Debtors Days Days34171 19.7%  
Net fixed assets Rs m55655,432 1.0%   
Share capital Rs m78268 29.0%   
"Free" reserves Rs m87813,935 6.3%   
Net worth Rs m1,06914,701 7.3%   
Long term debt Rs m1599,478 1.7%   
Total assets Rs m2,39973,988 3.2%  
Interest coverage x7.6-0.4 -2,135.0%   
Debt to equity ratio x0.10.6 23.0%  
Sales to assets ratio x1.70.1 1,787.2%   
Return on assets %6.40.5 1,279.7%  
Return on equity %11.6-27.3 -42.5%  
Return on capital %18.5-6.4 -287.2%  
Exports to sales %0.825.9 3.1%   
Imports to sales %1.40.2 824.5%   
Exports (fob) Rs m331,860 1.8%   
Imports (cif) Rs m5812 477.9%   
Fx inflow Rs m331,860 1.8%   
Fx outflow Rs m6325 253.9%   
Net fx Rs m-301,835 -1.7%   
CASH FLOW
From Operations Rs m1271,719 7.4%  
From Investments Rs m-146-3,148 4.6%  
From Financial Activity Rs m221,426 1.5%  
Net Cashflow Rs m3-3 -73.5%  

Share Holding

Indian Promoters % 65.4 33.9 192.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.0 -  
FIIs % 5.2 9.9 52.5%  
ADR/GDR % 0.0 16.9 -  
Free float % 25.8 39.3 65.6%  
Shareholders   12,723 21,482 59.2%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   UNICHEM LAB  VENUS REMEDIES  IPCA LABS  WOCKHARDT LTD.  AUROBINDO PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 18, 2017 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS